Performance Evaluation of ANI in Patients Under General Anesthesia With Remimazolam

Catholic Kwandong University

Status: Enrolling

Conditions: Pain Measurement

Treatments: Combination Product: Analgesia Nociception Index, remimazolam

Study type: Observational

Funder types: Other

Identifiers

NCT06432894

Ilsan_Cha_2023-04-003-005

Details and patient eligibility

About

The purpose of this study is to determine whether Analgesia Nociception Index (ANI) can effectively reduce the dose of opioid in patients who underwent general anesthesia using remimazolam.

Enrollment: 30 estimated patients

Sex: All

Ages: 20 to 79 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients

• aged 20-79 years under general anaesthesia with remimazolam
• scheduled to undergo robotic surgery
• in American Society of Anesthesiologists physical class 1, 2 or 3
• voluntarily agree in writing to participate in this clinical study

Exclusion criteria

• Conditions affecting the autonomic nervous system
• other conditions or disease that may cause acute or chronic pain
• the NRS before induction of anesthesia is 1 or over
• When taking medications that may affect the autonomic nervous system
• In other cases where the investigator deems the subject unsuitable for this trial

Trial design

30 participants in 1 patient group

observation

Description:

Patients * aged 20-80 years under general anaesthesia with remimazolam * scheduled to undergo robotic surgery * in American Society of Anesthesiologists physical class 1, 2 or 3

Treatment:

Combination Product: Analgesia Nociception Index, remimazolam